$0.080000
-0.01-11.85%
At Close: -
$0.067900
-0.01-15.12%
After Hours: Jun 24, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Biolase
BIOLOTCQB
want to know what
the Bulls & Bears Say?
Biolase (OTC:BIOL) Stock, Analyst Ratings, Price Targets, Forecasts
Biolase Inc has a consensus price target of $3.56 based on the ratings of 5 analysts. The high is $12 issued by Lake Street on May 20, 2022. The low is $0.4 issued by Benchmark on May 14, 2024. The 3 most-recent analyst ratings were released by Benchmark, Ascendiant Capital, and Benchmark on May 14, 2024, April 1, 2024, and March 22, 2024, respectively. With an average price target of $1.6 between Benchmark, Ascendiant Capital, and Benchmark, there's an implied 2256.41% upside for Biolase Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Ascendiant Capital
Lake Street
Maxim Group
Lake Street
1calculated from analyst ratings
Analyst Ratings for Biolase
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 489.1% | Benchmark | Bruce Jackson | → $0.4 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 04/01/2024 | Buy Now | 5791.02% | Ascendiant Capital | Edward Woo | $15 → $4 | Maintains | Buy | Get Alert |
| 03/22/2024 | Buy Now | 489.1% | Benchmark | Bruce Jackson | $2.5 → $0.4 | Maintains | Speculative Buy | Get Alert |
| 05/31/2023 | Buy Now | 489.1% | Lake Street | Frank Takkinen | $150 → $40 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 1372.75% | Maxim Group | Anthony Vendetti | $500 → $100 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | 2845.51% | Benchmark | Bruce Jackson | → $200 | Reiterates | → Speculative Buy | Get Alert |
| 01/20/2023 | Buy Now | 2109.13% | Lake Street | Frank Takkinen | → $150 | Assumes | → Buy | Get Alert |
| 05/20/2022 | Buy Now | 17573.05% | Lake Street | Kyle Bauser | → $1200 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Biolase (BIOL) stock?
The latest price target for Biolase (OTCQB:BIOL) was reported by Benchmark on May 14, 2024. The analyst firm set a price target for $0.40 expecting BIOL to rise to within 12 months (a possible 489.10% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biolase (BIOL)?
The latest analyst rating for Biolase (OTCQB:BIOL) was provided by Benchmark, and Biolase reiterated their speculative buy rating.
When was the last upgrade for Biolase (BIOL)?
There is no last upgrade for Biolase
When was the last downgrade for Biolase (BIOL)?
There is no last downgrade for Biolase.
When is the next analyst rating going to be posted or updated for Biolase (BIOL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biolase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biolase was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Biolase (BIOL) correct?
While ratings are subjective and will change, the latest Biolase (BIOL) rating was a reiterated with a price target of $0.40 to $0.40. The current price Biolase (BIOL) is trading at is $0.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.